HomeInsightsStock Comparison

Dr Reddys Laboratories Ltd vs Granules India Ltd Stock Comparison

Dr Reddys Laboratories Ltd vs Granules India Ltd Stock Comparison

Last Updated on: Jun 13, 2025

Key Highlights

  • The Latest Trading Price of Dr Reddys Laboratories Ltd is ₹ 1363 as of 12 Jun 15:30.
  • The P/E Ratio of Dr Reddys Laboratories Ltd changed from 25.6 on March 2020 to 18.4 on March 2024 . This represents a CAGR of -6.39% over 5 yearsThe P/E Ratio of Granules India Ltd changed from 10.9 on March 2020 to 25.7 on March 2024 . This represents a CAGR of 18.71% over 5 years.
  • The Market Cap of Dr Reddys Laboratories Ltd changed from ₹ 51797 crore on March 2020 to ₹ 102679 crore on March 2024 . This represents a CAGR of 14.67% over 5 yearsThe Market Cap of Granules India Ltd changed from ₹ 3650 crore on March 2020 to ₹ 10420 crore on March 2024 . This represents a CAGR of 23.34% over 5 years.
  • The revenue of Dr Reddys Laboratories Ltd for the Mar '25 is ₹ 9056 crore as compare to the Dec '24 revenue of ₹ 8535 crore. This represent the growth of 6.1% The revenue of Granules India Ltd for the Mar '25 is ₹ 1230 crore as compare to the Dec '24 revenue of ₹ 1143 crore. This represent the growth of 7.59%.
  • The ebitda of Dr Reddys Laboratories Ltd for the Mar '25 is ₹ 2525 crore as compare to the Dec '24 ebitda of ₹ 2427 crore. This represent the growth of 4.04% The ebitda of Granules India Ltd for the Mar '25 is ₹ 285.03 crore as compare to the Dec '24 ebitda of ₹ 235.97 crore. This represent the growth of 20.79%.
  • The net profit of Dr Reddys Laboratories Ltd changed from ₹ 1405 crore to ₹ 1586 crore over 8 quarters. This represents a CAGR of 6.27% The net profit of Granules India Ltd changed from ₹ 47.9 crore to ₹ 152.03 crore over 8 quarters. This represents a CAGR of 78.15% .
  • The Dividend Payout of Dr Reddys Laboratories Ltd changed from 14.14 % on March 2020 to 15.37 % on March 2024 . This represents a CAGR of 1.68% over 5 yearsThe Dividend Payout of Granules India Ltd changed from 5.72 % on March 2020 to 8.34 % on March 2024 . This represents a CAGR of 7.83% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dr Reddys Laboratories Ltd

  • Dr Reddy's Laboratories Limited (DRL) is an integrated global pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives.
  • Through its three businesses - Pharmaceutical Services &Active Ingredients, Global Generics and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including Active Pharmaceutical Ingredients (APIs), custom pharmaceutical services, generics, biosimilars and differentiated formulations.
  • The company's major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology.
  • Dr. Reddy's operates in markets across the globe.
  • Its major markets include - USA, India, Russia & CIS countries, and Europe. Dr Reddy's Laboratories Limited was incorporated in 1984 in Hyderabad.

About Granules India Ltd

  • Granules India Limited is a large-scale vertically integrated company founded in March 18th, 1991 manufacturing Active Pharmaceutical Ingredient (API), Pharmaceutical Formulation Intermediate (PFI) and Finished Dosage (FD).
  • With a strong presence across all three vertical, the company has created a leadership position in the off-patent drugs segment along with ensuring a strong presence in first line of defense' products such as Paracetamol, Ibuprofen, Metformin and Guaifenesin.
  • The company has a global presence across over 80 countries servicing over 300 customers.
  • Granules India is the preferred supplier for some of the world's leading pharma branded and generics companies.
  • The company has one of largest PFI and single site FD facilities in the world.

Dr Reddys Laboratories Ltd News Hub

News

Dr Reddys Laboratories Ltd up for third consecutive session

Dr Reddys Laboratories Ltd is up for a third straight session today. The stock is quoting ...

Read more

12 Jun 2025 13:05

News

Dr Reddys Laboratories Ltd soars 0.07%, up for fifth straight session

Dr Reddys Laboratories Ltd gained for a fifth straight session today. The stock is quoting...

Read more

09 Jun 2025 13:00

News

Alvotech and Dr Reddy's enter into collaboration and license agreement for pembrolizumab

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manu...

Read more

05 Jun 2025 09:20

News

Dr Reddys Lab gains on global biosimilar deal with Alvotech

Keytruda, a widely used immunotherapy for various cancer types, recorded global sales of $...

Read more

05 Jun 2025 10:10

News

Dr Reddys Laboratories allots 57,840 equity shares under ESOS

Dr Reddys Laboratories has allotted 57,840 equity shares of Re.1/- each of the Company, fu...

Read more

03 Jun 2025 16:28

News

Dr Reddys Labs' manufacturing facility gets two form 483 observations from US FDA

In a regulatory filing made on Saturday (24 May 2025), the company informed that the US FD...

Read more

26 May 2025 09:33

Granules India Ltd News Hub

News

Granules India announces cessation of Vice President & Head- IT

Granules India announced that Krishnamohan B., shall to be the Senior Management Personnel...

Read more

02 Jun 2025 12:46

News

Granules India to convene AGM

Granules India announced that the 34th Annual General Meeting(AGM) of the company will be ...

Read more

28 May 2025 14:10

News

Board of Granules India recommends final dividend

Granules India announced that the Board of Directors of the Company at its meeting held on...

Read more

28 May 2025 14:11

News

Granules India to declare Quarterly Result

Granules India will hold a meeting of the Board of Directors of the Company on 28 May 2025...

Read more

07 May 2025 11:42

News

Granules India completes acquisition of Swiss-based CDMO - Senn Chemicals AG

Granules India announced the successful closing of the acquisition of Senn Chemicals AG, a...

Read more

11 Apr 2025 10:15

News

Granules India allots 50,000 equity shares under ESOS

Granules India has allotted 50,000 equity shares under ESOS on 20 March 2025. Powered by C...

Read more

20 Mar 2025 19:46

SWOT Analysis Of Granules India Ltd

Strength

4

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

SWOT Analysis Of Dr Reddys Laboratories Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Granules India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Reddys Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dr Reddys Laboratories Ltd and Granules India Ltd

Which company has a larger market capitalization, Dr Reddys Laboratories Ltd or Granules India Ltd?

Market cap of Dr Reddys Laboratories Ltd is 113,756 Cr while Market cap of Granules India Ltd is 12,705 Cr

What are the key factors driving the stock performance of Dr Reddys Laboratories Ltd and Granules India Ltd?

The stock performance of Dr Reddys Laboratories Ltd and Granules India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Reddys Laboratories Ltd and Granules India Ltd?

As of June 13, 2025, the Dr Reddys Laboratories Ltd stock price is INR ₹1363.15. On the other hand, Granules India Ltd stock price is INR ₹523.85.

How do dividend payouts of Dr Reddys Laboratories Ltd and Granules India Ltd compare?

To compare the dividend payouts of Dr Reddys Laboratories Ltd and Granules India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions